#Hypertension(#āĻāĻ্āĻ_āĻ°āĻ্āĻ¤āĻাāĻĒ)
#Hypertension(#āĻāĻ্āĻ_āĻ°āĻ্āĻ¤āĻাāĻĒ)
āĻšাāĻāĻŦ্āĻ˛াāĻĄ āĻĒ্āĻ°েāĻ¸াāĻ° āĻāĻ āĻ§āĻ°āĻŖেāĻ° āĻ¨িāĻ°āĻŦ āĻাāĻ¤āĻāĻŦ্āĻ¯াāĻ§ি!
āĻšাāĻāĻĒ্āĻ°েāĻ¸াāĻ° āĻšāĻ্āĻে āĻŽাāĻ¨āĻŦ āĻĻেāĻšেāĻ° āĻ°āĻ্āĻ¤āĻাāĻĒ āĻ āĻ¸্āĻŦাāĻাāĻŦিāĻ āĻŦৃāĻĻ্āĻ§ি!āĻāĻŽāĻ°া āĻাāĻ¨ি āĻ¸িāĻ্āĻ°োāĻ˛িāĻ āĻĒ্āĻ°েāĻ¸াāĻ° ā§§ā§¨ā§Ļ āĻŽিāĻ˛িāĻŽিāĻাāĻ° āĻŽাāĻ°্āĻাāĻ°ী āĻ āĻĄাā§াāĻ¸্āĻāĻ˛িāĻ āĻĒ্āĻ°েāĻ¸াāĻ° ā§Žā§Ļ āĻŽিāĻ˛িāĻŽিāĻাāĻ° āĻŽাāĻ°্āĻাāĻ°ী āĻ¸্āĻŦাāĻাāĻŦিāĻ āĻ°āĻ্āĻ¤āĻাāĻĒ।āĻিāĻ¨্āĻ¤ু āĻŦā§āĻ¸āĻেāĻĻে āĻāĻ° āĻ āĻ¨েāĻāĻা āĻ¤াāĻ°āĻ¤āĻŽ্āĻ¯ āĻ°ā§েāĻে,āĻāĻ¸ুāĻ¨ āĻেāĻ¨ে āĻ¨েāĻ āĻ¸্āĻŦাāĻাāĻŦিāĻ āĻŦ্āĻ˛াāĻĄ āĻĒ্āĻ°েāĻ¸াāĻ°,
#āĻŦā§āĻ¸:ā§§āĻĨেāĻে ā§§ā§¨āĻŽাāĻ¸-ā§¯ā§Ļ/ā§Ŧā§Ļ āĻŽিāĻ˛িāĻŽিāĻাāĻ° āĻŽাāĻ°্āĻাāĻ°ী
#āĻŦā§āĻ¸:ā§§-ā§ĢāĻŦā§āĻ¸āĻ° -ā§¯ā§Ģ/ā§Ŧā§Ģ āĻŽিāĻ˛িāĻŽিāĻাāĻ° āĻŽাāĻ°্āĻাāĻ°ী
#āĻŦā§āĻ¸:ā§Ŧ-ā§§ā§Š āĻŦā§āĻ¸āĻ° -ā§§ā§Ļā§Ģ/ā§ā§Ļ āĻŽিāĻ˛িāĻŽিāĻাāĻ° āĻŽাāĻ°্āĻাāĻ°ী
#āĻŦā§āĻ¸:ā§§ā§Ē-ā§§ā§¯ āĻŦā§āĻ¸āĻ° -ā§§ā§§ā§/ā§ā§āĻŽিāĻ˛িāĻŽিāĻাāĻ° āĻŽাāĻ°্āĻাāĻ°ী
#āĻŦā§āĻ¸:ā§¨ā§Ļ-ā§¨ā§Ē āĻŦā§āĻ¸āĻ° -ā§§ā§¨ā§Ļ/ā§ā§¯ āĻŽিāĻ˛িāĻŽিāĻাāĻ° āĻŽাāĻ°্āĻাāĻ°ী
#āĻŦā§āĻ¸:ā§¨ā§Ģ-ā§¨ā§¯ āĻŦā§āĻ¸āĻ° -ā§§ā§Šā§Ē/ā§Žā§Ģ " "
#āĻŦā§āĻ¸:ā§Šā§Ļ-ā§Šā§Ē āĻŦā§āĻ¸āĻ° -ā§§ā§Šā§Ģ/ā§Žā§Ŧ " "
#āĻŦā§āĻ¸:ā§Šā§Ģ-ā§Šā§¯ āĻŦā§āĻ¸āĻ° -ā§§ā§Šā§/ā§Žā§ " "
#āĻŦā§āĻ¸:ā§Ēā§Ļ-ā§Ēā§Ē āĻŦā§āĻ¸āĻ° -ā§§ā§Šā§Ž/ā§Žā§Ž " "
#āĻŦā§āĻ¸:ā§Ēā§Ģ-ā§Ēā§¯ āĻŦā§āĻ¸āĻ° -ā§§ā§Šā§¯/ā§Žā§Ž " "
#āĻŦā§āĻ¸:ā§Ģā§Ļ-ā§Ģā§Ē āĻŦā§āĻ¸āĻ° -ā§§ā§Ēā§¨/ā§Žā§¯ " "
#āĻŦā§āĻ¸:ā§Ģā§Ģ-ā§Ģā§¯ āĻŦā§āĻ¸āĻ° -ā§§ā§Ēā§Ē/ā§¯ā§Ļ " "
#āĻŦā§āĻ¸ :ā§Ŧā§Ļ-ā§Ŧā§Ē āĻŦā§āĻ¸āĻ° -ā§§ā§Ēā§/ā§¯ā§§ " "
#āĻĒ্āĻ°েāĻāĻ¨্āĻ¯াāĻ¨্āĻ āĻŽাā§েāĻ° : ā§§ā§Ēā§Ļ/ā§¯ā§Ļ āĻŽিāĻ˛িāĻŽিāĻাāĻ° āĻŽাāĻ°্āĻাāĻ°ী
#āĻšাāĻāĻĒাāĻ°āĻেāĻ¨āĻļāĻ¨:
#āĻ্āĻ°েāĻĄ ā§§:(āĻŽাāĻāĻ˛্āĻĄ)-ā§§ā§Ģā§¯/ā§¯ā§¯ āĻŽিāĻ˛িāĻŽিāĻাāĻ° āĻŽাāĻ°্āĻাāĻ°ী
#āĻ্āĻ°েāĻĄ ā§¨:(āĻŽāĻĄাāĻ°েāĻ)-ā§§ā§ā§¯/ā§§ā§Ļā§¯ āĻŽিāĻ˛িāĻŽিāĻাāĻ° āĻŽাāĻ°্āĻাāĻ°ী
#āĻ্āĻ°েāĻĄ ā§Š:(āĻ¸িāĻিā§াāĻ°)->ā§§ā§Žā§Ļ/ā§§ā§§ā§Ļ āĻŽিāĻ˛িāĻŽিāĻাāĻ° āĻŽাāĻ°্āĻাāĻ°ী
#āĻĒ্āĻ¯াāĻĨāĻĢিāĻিāĻāĻ˛āĻী:
~Preload
BP= Cardiac output ~stroke volume^ ~Myocardial
~HR Contractility
~Afterload
Peripheral Resistance ~^Vascular tone
~ Vascular structure^~Remodelling
~Rarefaction
#āĻāĻŦাāĻ°_āĻেāĻ¨ে_āĻ¨েāĻā§া_āĻ¯াāĻ_āĻāĻŽাāĻĻেāĻ°_āĻĻেāĻšেāĻ°_āĻ°āĻ্āĻ¤āĻাāĻĒ_āĻাāĻ°া_āĻ¨িā§āĻ¨্āĻ¤্āĻ°āĻŖ_āĻāĻ°ে,
#Baroreceptor
#Chemoreceptor
#Sympathetic and parasympathetic action
#Cardic output
#Heart Rate
#ADH
#Renin Angiotenosin
#Angiotenosiogen
#Erythoprotein
#Peripheral Resistance
#Capillary permeability
#Aldostorene
#O2 supply
#etc
#āĻāĻ্āĻ_āĻ°āĻ্āĻ¤āĻাāĻĒেāĻ°_āĻাāĻ°āĻ¨ :
#āĻĒ্āĻ°াāĻāĻŽাāĻ°ি :
@Environment Factor
@Genetic
@Vitamin D deficiency
@Insulin resistance
@Metabolic disorder
@sold intake more
@Low birth weight
@Maternal smoking
@High blood urea
#āĻ¸েāĻেāĻ¨্āĻĄাāĻ°ি:
*Kidney Disease
*Endrocrine Condition (Hyperthyriodism,Hyperaldosteronism,Cushing syndrome etc)
*Obesity
*Pregency
*sleep apnea
*etc
#āĻāĻ্āĻ_āĻ°āĻ্āĻ¤āĻাāĻĒেāĻ°_āĻāĻĒāĻ¸āĻ°্āĻ :
$āĻŽাāĻĨা āĻŦ্āĻ¯াāĻĨা
$āĻŽাāĻĨা āĻুāĻ°াāĻ¨ো
$āĻাā§েāĻ° āĻĒিāĻāĻ¨ে āĻŦা āĻŽাāĻĨাāĻ° āĻĒিāĻāĻ¨ে āĻŦ্āĻ¯াāĻĨা āĻ āĻ¨ুāĻāĻŦ
$āĻোāĻে āĻাāĻĒāĻ¸া āĻĻেāĻা
$āĻাāĻ¨েāĻ° āĻŽāĻ§্āĻ¯ে āĻূ āĻূ āĻāĻ°া
$āĻ āĻ¸্āĻĨিāĻ° āĻ āĻ¨ুāĻāĻŦ
$āĻļāĻ°ীāĻ°ে āĻাāĻŽ āĻšā§ে āĻĨাāĻে
$āĻুāĻŽে āĻŦ্āĻ¯াāĻাāĻ¤
$āĻ āĻŦāĻ¸াāĻĻāĻ্āĻ°āĻ¸্āĻ¤
$āĻ āĻ˛্āĻĒāĻ¤েāĻ āĻĒāĻ°িāĻ¸্āĻ°āĻŽ āĻ āĻ্āĻ˛াāĻ¨্āĻ¤
$āĻāĻ¤্āĻ¯াāĻĻি
#āĻāĻ্āĻ āĻ°āĻ্āĻ¤āĻাāĻĒ āĻĨেāĻে āĻ āĻ¨্āĻ¯ āĻāĻ°ো āĻি āĻ°োāĻ āĻšāĻ¤ে āĻĒাāĻ°ে,
$Coronary artery disease
$stroke
$Heart Failure
$Atrial Fibrillation
#peripheral vascular disease
#vission loss
#Demestia
#CKD
#pulmonary Embolism
#Hypertensive Retinopathy
#Hypertensive Nepropathy
#MI
#Heart attack
#etc
#āĻ¯াāĻĻেāĻ° āĻāĻ্āĻ āĻ°āĻ্āĻ¤āĻাāĻĒ āĻšāĻā§াāĻ° āĻ¸āĻŽ্āĻāĻ¨া āĻāĻে,
@āĻ āĻ¤িāĻ°িāĻ্āĻ¤ āĻ˛āĻŦāĻŖ āĻাāĻā§া
@āĻ āĻ¤িāĻ°িāĻ্āĻ¤ āĻļāĻ°ীāĻ°েāĻ° āĻāĻāĻ¨
@āĻ§ুāĻŽāĻĒাāĻ¨
@āĻāĻ˛āĻোāĻšāĻ˛ āĻĒাāĻ¨
@āĻĄাā§াāĻŦেāĻিāĻāĻ¸
@āĻ āĻ¤িāĻ°িāĻ্āĻ¤ āĻĢ্āĻ¯াāĻ āĻ¯াāĻĻেāĻ° āĻāĻে
@āĻāĻ¤্āĻ¯াāĻĻি
#āĻāĻ্āĻāĻ°āĻ্āĻ¤āĻাāĻĒেāĻ° āĻĒ্āĻ°ā§োāĻāĻ¨ীā§ āĻĒāĻ°িāĻ্āĻˇা :
*Kidney:Serum Creatinine, Protein in the urine,BUN,
*Endocrine :TSH,serum calcium,Serum Electrolytic
*Metabolic :RBS,Lipid profile
*Heart: ECG,Chest x-ray.
#Management:
@Life style changes :
#āĻļাāĻ°ীāĻ°িāĻ āĻŦ্āĻ¯াā§াāĻŽ āĻ¨িā§āĻŽিāĻ¤,
#āĻাāĻŦাāĻ°ে āĻ āĻ¤িāĻ°িāĻ্āĻ¤ āĻ˛āĻŦāĻ¨ āĻĒāĻ°িāĻšাāĻ°,
#āĻŽিāĻ¸্āĻি āĻাāĻ¤ীā§ āĻাāĻŦাāĻ° āĻŦāĻ°্āĻāĻ¨,
#āĻ āĻ¤িāĻ°িāĻ্āĻ¤ āĻĢ্āĻ¯াāĻ āĻাāĻŦাāĻ° āĻĒāĻ°িāĻšাāĻ°,
#āĻļāĻ°ীāĻ°েāĻ° āĻāĻāĻ¨ āĻāĻŽাāĻ¤ে āĻšāĻŦে,
#āĻ§ুāĻŽāĻĒাāĻ¨ āĻ¨িāĻˇেāĻ§,
#āĻāĻ˛āĻোāĻšāĻ˛ āĻĒাāĻ¨ āĻŦিāĻ°āĻ¤,
#āĻĄাā§োāĻ āĻāĻ¨্āĻ্āĻ°োāĻ˛
#āĻāĻ¤্āĻ¯াāĻĻি
@Medication:
*Beta-Blocker
*Calcium channel Blocker
*ACE inhibitor
*Angiotenosin Receptor Blocker
*Thiazide Diruties
*Alpha 1 Blocker
*Renin Inhibitor
*Others
āĻ°েāĻĢাāĻ°েāĻ¨্āĻ¸ : Davidson's Medicine,Harrisons principles of internal medicine,American Heart Association Guide line,US MLE part 2.
#āĻļুāĻāĻাāĻŽāĻ¨াā§,āĻ§āĻ¨্āĻ¯āĻŦাāĻĻ #
No comments